Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
NASDAQ:CBLL
CBLL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.01 - $32.75
Previous CloseN/A
Volume46.56K
Average Volume (3M)308.89K
Market Cap
$619.49M
Enterprise ValueN/A
Total Cash (Recent Filing)$194.37M
Total Debt (Recent Filing)$21.96M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Nov 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding36,143,020
10 Day Avg. Volume300,950
30 Day Avg. Volume308,888
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)3.63
Price to Sales (P/S)0.00
P/FCF Ratio-21.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$31.80Price Target Upside81.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Ceribell, Inc. News
PremiumCompany Announcements
Ceribell, Inc. Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Ceribell, Inc. Reports Strong Q1 2025 GrowthBulls Say, Bears Say
Bulls Say
Expansion OpportunitiesManagement is confident in the company’s strong underlying fundamentals continuing with further momentum expected from expansion opportunities.
Financial GuidanceThe company raised its full-year revenue guidance to a range of $83M to $87M, which implies growth of 27% to 33%.
Revenue GrowthCBLL reported a strong 1Q performance which saw the company deliver total revenue of $20.5M, up 42% from the same period last year.
Bears Say
Manufacturing ConcernsThe company is assessing all potential options for manufacturing relocation, including moving to Mexico or other geographies in Asia.
Stock Price DeclineThe stock has fallen 35% largely due to China manufacturing exposure and lock-up expiration.
Tariff HeadwindsPotential headwinds from incremental tariffs are not expected to impact margins until the fourth quarter.
Ownership Overview
27.78% Insiders
19.73% Mutual Funds
37.72% Other Institutional Investors
11.20% Public Companies and Individual Investors
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $10.01 and its highest was $32.75 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $619.49M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 164 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on May 08, 2025. The company reported -$0.36 earnings per share for the quarter, beating the consensus estimate of -$0.407 by $0.047.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 36,143,020 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.36 in its last earnings report, beating expectations of -$0.407. Following the earnings report the stock price went down -6.608%.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
Ceribell, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.80 (81.71% Upside)
$31.80 (81.71% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 281.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $6.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Company Description
Ceribell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
CBLL Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, high gross margins, expansion of active accounts, and important regulatory achievements, such as FDA clearance and FedRAMP authorization. However, the increase in operating expenses and net loss, along with potential impacts from increased tariffs, present challenges. Despite these lowlights, the positive aspects, including strategic achievements and financial growth, suggest a confident outlook.Read More>CBLL Stock 12 Month Forecast
Average Price Target
$31.80
▲(81.71%Upside)